Search - tctmd.com

Displaying 401 - 420 of 421

Sort: Relevancy | Date

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

CIBELES: Xience Stands Up to Cypher for CTO PCI

Caitlin E. Cox

May 17, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

Presentation GI2 2012

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Presenter: Jose Ribamar Costa

April 11, 2012

Presentation TCT 2012

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT

Presenter: Juan Luis Guti?rrez-Chico, Patrick W. Serruys, Chrysafios Girasis, Yoshinobu Onuma, Salvatore Brugaletta, H?ctor Manuel Garc?a-Garc?a, Evelyn Regar

January 03, 2012

Presentation TCT 2012

Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow...

Presenter: Jose M. De la Torre Hernandez, Dae-Hyun Lee, Tamara Garcia Camarero, Piedad Lerena, Gonzalo Martin Gorria, Fermin Sainz Laso, Javier Zueco

January 03, 2012

News Daily News

Stenting, Surgery Achieve Good Hemodynamic Outcomes in Native Aortic Coarctation

Jason Kahn

December 04, 2011

News Conference News

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

November 20, 2011

News Industry News

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

November 13, 2011

News Daily News

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

October 21, 2011

News Daily News

IVUS Guidance of DES Implantation Improves Outcomes

September 28, 2011

News Daily News

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

Caitlin E. Cox

August 05, 2011

News Conference News

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

May 23, 2011

News Conference News

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Caitlin E. Cox

May 20, 2011

News Conference News

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

Jason Kahn

May 19, 2011

News Daily News

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

Jason Kahn

April 28, 2011

News Conference News

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

Caitlin E. Cox

April 08, 2011

News Daily News

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Caitlin E. Cox

March 25, 2011

News Daily News

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

March 01, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

Advertisement

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

CIBELES: Xience Stands Up to Cypher for CTO PCI

Strong Showing for Bioabsorbable-Scaffold DES

Focus on In-Stent Restenosis: Imaging to Guide the Best Treatment

Quantitative multi-modality imaging analysis of a fully bioresorbable scaffold: a head-to-head comparison between QCA, IVUS and OCT

Comparison by Optical Frequency-Domain Imaging of Paclitaxel-Eluting Stents and Everolimus-Eluting Stents Implanted in One Coronary Artery in One Procedure. A 12 Months Follow...

Stenting, Surgery Achieve Good Hemodynamic Outcomes in Native Aortic Coarctation

Paclitaxel-Eluting Bioabsorbable Stent Shows Advantage over Bare-Metal Version

REMEDEE Study Meets Primary Endpoint: OrbusNeich’s Combo™ Dual Therapy Stent Is Non-Inferior to DES

Early Study Shows Pelvic Stenting for Erectile Dysfunction Safe, Feasible

IVUS Guidance of DES Implantation Improves Outcomes

SES Fractures Raise Revascularization Risk, But Not Beyond 1 Year

EuroPCR 2011: Novel Technologies with Transformative Potential Stand Out

Meta-analysis: Biodegradable Polymer DES Reduce Stent Thrombosis, TLR at 3 Years

Long-Term Imaging Study Evaluates Vascular Healing in First-Gen DES

DES Add Over $1.5 Billion in Medicare Costs to Health Care System

ACC Scientific Session-i2 Summit 2011: The Devil Is in the Details

In Vivo Study Suggests DES Polymer-Drug Coatings Not Inherently Thrombogenic

Autopsy Study: About One-Third of DES Contain New Atherosclerosis

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content